Increasing Optimal Use of HPV Vaccination in Primary Care

Randomized Controlled Trial to Evaluate an Implementation Strategy to Increase Optimal Use of HPV Vaccine in Primary Care

Washington University will evaluate the effectiveness of a multi-component implementation strategy to increase use of HPV vaccine in primary care practices.

The investigators at Washington University will complete a cluster-randomized trial to evaluate the effectiveness of a multi-component implementation strategy (the intervention) to increase use of the HPV vaccine according to CDC guidelines. The unit of randomization is a community-based, primary care pediatric practice. Twenty practices will be randomized into two groups, the intervention group (n=10) or a wait-list control group (n=10). The intervention will be implemented over 2-years and includes: 1) an educational video for providers; 2) audit and feedback of vaccine coverage; 3) a communication strategy; and 4) practice facilitation.

The primary outcome of HPV vaccination by age 13 will be assessed at 24 months, and at 36 months to assess if change is sustained.

Inclusion Criteria

Practices:

• Community-based pediatric primary care practices with 2 or more providers.
• Providers who deliver wellness care to preteens and adolescents.
• Willingness to participate in the practice facilitator-guided QI process.

Providers:

• Providers who deliver wellness care to preteens and adolescents.
• Willingness to complete study questionnaires.
• Willingness to participate in the practice facilitator-guided QI process.

EXCLUSION CRITERIA

• Practices and providers may be excluded at the discretion of the PI.